Loading clinical trials...
Loading clinical trials...
Evaluation of Non-Surgical Venous Thromboembolism Prophylaxis Dosing Strategies: Enoxaparin 20mg Versus 30mg Subcutaneously Once Daily in Elderly Patients With Impaired Renal Function
Conditions
Interventions
Enoxaparin 20Mg/0.2mL Prefilled Syringe
Enoxaparin 60Mg/0.6Ml Inj Syringe 0.6Ml
Locations
1
Lebanon
LAU Medical Center-Rizk Hospital
Beirut, Lebanon
Start Date
October 24, 2015
Primary Completion Date
July 13, 2017
Completion Date
July 13, 2017
Last Updated
September 11, 2017
NCT06189313
NCT07015905
NCT03728166
NCT07154901
NCT07310693
NCT07288632
Lead Sponsor
Lebanese American University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions